当前位置:首页 - 行情中心 - 红日药业(300026) - 财务分析 - 现金流量表

红日药业

(300026)

  

流通市值:100.54亿  总市值:100.64亿
流通股本:30.01亿   总股本:30.04亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,258,058,257.465,715,513,731.454,462,596,762.162,997,419,802.78
  收到的税费返还3,868,638.0238,191,947.2634,027,369.7132,208,346.17
  收到其他与经营活动有关的现金33,364,931.2263,549,213.32104,610,751.5566,733,792.5
  经营活动现金流入小计1,295,291,826.75,817,254,892.034,601,234,883.423,096,361,941.45
  购买商品、接受劳务支付的现金417,972,809.681,831,632,871.121,554,725,075.471,085,523,597.89
  支付给职工以及为职工支付的现金251,039,051.95875,668,988.54687,212,806.45472,725,065.67
  支付的各项税费130,197,089.28490,180,770.97368,304,475.51251,109,516.57
  支付其他与经营活动有关的现金404,704,418.471,808,430,650.611,454,155,889.5903,470,759.79
  经营活动现金流出小计1,203,913,369.385,005,913,281.244,064,398,246.932,712,828,939.92
  经营活动产生的现金流量净额91,378,457.32811,341,610.79536,836,636.49383,533,001.53
二、投资活动产生的现金流量:
  收回投资收到的现金-661,091.33661,091.3343,771.36
  处置固定资产、无形资产和其他长期资产收回的现金净额8,728.3703,899.49496,913.03239,470
  收到的其他与投资活动有关的现金-1,540,0001,540,0001,540,000
  投资活动现金流入小计8,728.32,904,990.822,698,004.361,823,241.36
  购建固定资产、无形资产和其他长期资产支付的现金28,836,828.69130,249,796.0396,062,756.2574,486,165.72
  投资活动现金流出小计28,836,828.69130,249,796.0396,062,756.2574,486,165.72
  投资活动产生的现金流量净额-28,828,100.39-127,344,805.21-93,364,751.89-72,662,924.36
三、筹资活动产生的现金流量:
  取得借款收到的现金794,748.8955,331,629.0551,259,969.0651,108,829.34
  筹资活动现金流入小计794,748.8955,331,629.0551,259,969.0651,108,829.34
  偿还债务支付的现金11,338,600352,520,132.77228,127,962.39206,439,362.39
  分配股利、利润或偿付利息支付的现金5,995,789.4122,973,706.96110,281,541.99104,765,857.13
  其中:子公司支付给少数股东的股利、利润3,136,00017,575,913.218,752,313.217,147,274.27
  支付其他与筹资活动有关的现金15,083,160.349,850,103.3342,608,799.6725,513,504.19
  筹资活动现金流出小计32,417,549.7525,343,943.06381,018,304.05336,718,723.71
  筹资活动产生的现金流量净额-31,622,800.81-470,012,314.01-329,758,334.99-285,609,894.37
四、汇率变动对现金及现金等价物的影响-4,993,071.72-3,456,522.37-694,148.831,058,021.3
五、现金及现金等价物净增加额25,934,484.4210,527,969.2113,019,400.7826,318,204.1
  加:期初现金及现金等价物余额1,483,651,060.81,273,123,091.61,273,123,091.61,273,123,091.6
  期末现金及现金等价物余额1,509,585,545.21,483,651,060.81,386,142,492.381,299,441,295.7
补充资料:
  净利润-22,223,495.61-84,622,983.01
  资产减值准备-238,528,350.71-37,083,154.76
  固定资产和投资性房地产折旧-247,900,563.9-123,248,763.27
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-247,900,563.9-123,248,763.27
  无形资产摊销-34,361,030.65-17,992,055.32
  长期待摊费用摊销-27,921,084.53-16,719,902.8
  处置固定资产、无形资产和其他长期资产的损失--702,535.55-1,887.72
  固定资产报废损失-1,248,282.67-84,547.22
  财务费用-25,374,703.59-12,663,387.1
  投资损失-3,658,808.4-2,421,568.53
  递延所得税--9,484,132.68-3,726,570.03
  其中:递延所得税资产减少--1,238,114.57-8,863,756.32
    递延所得税负债增加--8,246,018.11--5,137,186.29
  存货的减少-255,248,103.48-105,931,942.99
  经营性应收项目的减少-252,022,267.38--5,692,626.01
  经营性应付项目的增加--329,863,767.03--36,060,609.14
  其他--6,021,944.1--2,755,201.47
  现金的期末余额-1,483,651,060.8-1,299,441,295.7
  减:现金的期初余额-1,273,123,091.6-1,273,123,091.6
  现金及现金等价物的净增加额-210,527,969.2-26,318,204.1
公告日期2026-04-292026-04-212025-10-292025-08-28
审计意见(境内)标准无保留意见
TOP↑